Method for promoting hair growth comprising implanting a tissue scaffold comprising CK-19 positive cells derived from Wharton's jelly mesenchymal stromal cells

Patent metadata

Field	Value
Publication number	US-9814802-B2
Application number	US-201313874054-A
Country	US
Kind code	B2
Filing date	Apr 30, 2013
Priority date	Apr 30, 2012
Publication date	Nov 14, 2017
Grant date	Nov 14, 2017

Abstract

A method of differentiating cells into CK19-positive cells capable of producing hair follicle-like and hair structure-like can include: providing a tissue scaffold; seeding cells into the scaffold, the cells being capable of differentiation; incubating the scaffold having the cells in a cell growth media; and incubating the scaffold having the cells in an osteogenic differentiation medium sufficient for CK19-positive cells to be generated in the scaffold. The tissue scaffold can be a decellularized Whartons' jelly matrix. The cell growth media excludes osteogenic differentiation components: dexamethasone, β-glycerophosphate, 1α,25-hydroxyvitamin D3, and ascorbic acid 2-phosphate. The osteogenic differentiation medium includes the osteogenic differentiation components. The cells can be mesenchymal cells, such as WJMSCs.

First claim

The invention claimed is:

1. A method for promoting hair growth comprising: (A) providing a tissue scaffold comprising CK19-positive cells in a decellularized Wharton's jelly matrix, wherein the CK19-positive cells are derived from Wharton's jelly mesenchymal stromal (WJMS) cells that have been seeded on the decellularized Wharton's jelly matrix and then incubated in an osteogenic differentiation media; and (B) implanting the tissue scaffold into a skin surface of a subject such that implantation of the tissue scaffold promotes hair growth at or close to the surface of the skin.

2. The method of claim 1 wherein the tissue scaffold is implanted into a scalp of the subject.

3. The method of claim 1 wherein one or more of versican, sonic hedgehog, and bone morphogenic protein-4 (BMP-4) is detected in a region in the tissue scaffold.

4. The method of claim 3 wherein the tissue scaffold comprises CK19-positive cells that have differentiated into condensed cells or are in the process of differentiating into condensed cells and wherein one or more layers of spindle-like cells overlay the area of condensed cells.

5. The method of claim 4 wherein the tissue scaffold comprises a placode.

6. The method of claim 1 wherein prior to (A), providing the WJMS cells; seeding the WJMS cells on the tissue scaffold comprising decellularized Wharton's jelly matrix; and incubating the tissue scaffold comprising the decellularized Wharton's jelly matrix seeded with WJMS cells in the osteogenic differentiation media until the WJMS cells seeded on the decellularized Wharton's jelly matrix differentiate into CK19-positive cells.

7. The method of claim 1 wherein the tissue scaffold comprises one or more of: mesenchymal cell condensation, hair placode formation, spindle-like cell layer, and hair follicle formation.

8. The method of claim 5 wherein the tissue scaffold is implanted into a scalp of a subject.

9. The method of claim 1 wherein prior to (A), providing the tissue scaffold comprising decellularized Wharton's jelly matrix; seeding WJMS cells on the tissue scaffold comprising decellularized Wharton's jelly matrix; incubating the tissue scaffold comprising the decellularized Wharton's jelly matrix seeded with WJMS cells in a cell growth media; and incubating the tissue scaffold comprising the decellularized Wharton's jelly matrix seeded with WJMS cells in the osteogenic differentiation media until the WJMS cells differentiate into CK19-positive cells.

10. The method of claim 9 wherein prior to providing the tissue scaffold comprising decellularized Wharton's jelly matrix, the Wharton's jelly matrix is decellularized and the decellularization process removes all cells and cellular elements from the Wharton's jelly matrix.

11. The method of claim 9 , wherein the cell growth media excludes: dexamethasone, β-glycerophosphate, 1α, 25-hydroxyvitamin D3, and ascorbic acid 2-phosphate.

12. The method of claim 1 wherein the matrix has interstitial spaces.

13. The method of claim 9 wherein the seeded WJMS cells are incubated in the tissue scaffold comprising decellularized Wharton's jelly matrix in the osteogenic differentiation media until one or more of versican, sonic hedgehog, and bone morphogenic protein-4 (BMP-4) is detected in a region in the tissue scaffold.

14. The method of claim 12 wherein the seeded WJMS cells are incubated in the tissue scaffold comprising decellularized Wharton's jelly matrix in the osteogenic differentiation media until an area of condensed cells forms with one or more layers of spindle-like cells over the area of condensed cells.

15. The method of claim 14 wherein the seeded WJMS cells are incubated in the tissue scaffold comprising decellularized Wharton's jelly matrix in the osteogenic differentiation media until a placode is formed.

16. The method of claim 15 wherein the seeded WJMS cells are incubated in the tissue scaffold comprising decellularized Wharton's jelly matrix in the osteogenic differentiation media until a hair follicle-like structure is formed.

17. The method of claim 15 wherein the seeded WJMS cells are incubated in the tissue scaffold comprising decellularized Wharton's jelly matrix in the osteogenic differentiation media until an osteogenic portion is obtained.

18. The method of claim 1 wherein prior to (A) providing the tissue scaffold comprising decellularized Wharton's jelly matrix; seeding WJMS cells on the tissue scaffold comprising decellularized Wharton's' jelly matrix; incubating the tissue scaffold comprising the decellularized Wharton's jelly matrix seeded with WJMS cells in an expansion media; and incubating the tissue scaffold comprising the decellularized Wharton's jelly matrix seeded with WJMS cells in the osteogenic differentiation media until spheroids comprising the CK19-positive cells are obtained.

19. The method of claim 18 wherein prior to (A) providing the tissue scaffold comprising decellularized Wharton's jelly matrix; seeding WJMS cells on the tissue scaffold comprising decellularized Wharton's jelly matrix; incubating the tissue scaffold comprising the decellularized Wharton's jelly matrix seeded with WJMS cells in the osteogenic media until one or more of (1) one or more of versican, sonic hedgehog, and bone morphogenic protein-4 (BMP-4) is detected in a region in the tissue scaffold; (2) an area of condensed cells forms with one or more layers of spindle-like cells over the area of condensed cells; (3) a placode is formed and (4) a hair follicle-like structure is formed.

Assignees

• Univ Kansas
• The Children'S Mercy Hospital

Inventors

• Aljitawi Omar
• Hopkins Richard
• Detamore Michael
• Garimella Rama

Classifications

• A61L27/3683 Primary

  subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment · CPC title

• A61L27/3804

  characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells · CPC title

• A61L27/3604 Primary

  characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel · CPC title

• A61L2430/18

  for hair reconstruction · CPC title